News - solanezumab, Patents

Filter

Current filters:

solanezumabPatents

Popular Filters

Mixed news on Lilly's Alzheimer's drug solanezumab; Alimta patent upheld

28-08-2012

US drug major Eli Lilly (NYSE: LLY) revealed last Friday that the primary endpoints, both cognitive and…

AlimtaEli LillyLegalNeurologicalNorth AmericaOncologyPatentsPharmaceuticalResearchsolanezumabTeva Pharmaceutical Industries

Back to top